five

αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors

收藏
NIAID Data Ecosystem2026-03-11 收录
下载链接:
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2348111
下载链接
链接失效反馈
官方服务:
资源简介:
This is a single arm, open-label, dose escalation clinical study to evaluate the safety and tolerability of autologous mesothelin (MSLN)-targeted chimeric antigen receptor (MSLN-CAR) T cells secreting PD-1 nanobodies (αPD1-MSLN-CAR T cells) in patients with solid tumors.
创建时间:
2020-03-15
二维码
社区交流群
二维码
科研交流群
商业服务